Literature DB >> 22088986

Assessing patient accrual to cooperative group lung cancer trials: why are rates disappointing?

Brian E Lally, Henry Wagner, Corey Langer, Charles R Thomas.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22088986     DOI： 10.1097/JTO.0b013e3182370deb

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  2 in total

1.  Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group.

Authors:  H H Strøm; R M Bremnes; S H Sundstrøm; N Helbekkmo; O Fløtten; U Aasebø
Journal:  Br J Cancer       Date:  2013-08-20       Impact factor: 7.640

2.  Searching for cures: Inner-city and rural patients' awareness and perceptions of cancer clinical trials.

Authors:  Mugur Geana; Joseph Erba; Hope Krebill; Gary Doolittle; Sheshadri Madhusudhana; Abdulraheem Qasem; Nikki Malomo; Denise Sharp
Journal:  Contemp Clin Trials Commun       Date:  2016-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.